Abstract: The present invention relates to a metal-organic framework (MOF) having a three-dimensional porous structure and being represented by the chemical formula of [Al8(OH)a(BTC)b(IPA)c(L)d], a preparation method therefor, and a use thereof as an adsorbent and a catalyst.

Abstract: The present invention relates to a method of assisting the diagnosis of metastatic castration resistant prostate cancer, including measuring an amount of an extracellular vesicle having phosphatidylserine and a prostate specific membrane antigen in a biological specimen derived from a subject; and determining whether or not the subject has metastatic castration resistant prostate cancer by using, as an indicator, the amount of the extracellular vesicle having phosphatidylserine and a prostate specific membrane antigen.

Abstract: Systems and methods for selecting a channel of communication based on a type of thinking employed by a user for a task are disclosed. The systems and methods include determining that a user is employing System 1 type thinking or System 2 type thinking for the task based on one or more properties of the task, one or more properties of the user, and a state of the user based on physiological response data from one or more physiological sensors monitoring the user, and implementing a channel of communication to utilize for the task that corresponds to a determined type of thinking the user is employing for the task.

Abstract: Provided are a serial communication device and a serial communication system for a memory access. The serial communication device for a memory access may include: a system-on-chip (SoC) bus interface receiving a request transaction from a hardware acceleration device; a master protocol processor converting a request transaction received through the SoC bus interface into a packet according to a predetermined packet protocol; and a serial transceiver serial-transmitting the packet.

Abstract: The present disclosure discloses a power device including at least one vacuum packaged unit structure. The unit structure comprises a silicon substrate (100) and an emitter (200), a light modulator (300) and a collector (400) formed on the silicon substrate (100). On the one hand, the unified silicon-based process is compatible with the existing commercial process, so that it is easy for integration, simple for manufacture, and low in cost; on the other hand, the light modulator (300) is introduced and formed on the silicon substrate by a silicon-based process, which enhances field emission efficiency of the emitter (200), offsets the inconsistency of distances between the tips of the emitters (200) and the collector (400) caused by unevenness of the emitters, and increases the process redundancy of the cold cathode emitter.

Abstract: Provided herein are compounds, compositions and methods of using thereof for treatment and/or prevention infections of viruses such as HIV and HBV by administering a certain esters and other derivatives of 4?-ethynyl-2-fluoro-2?-deoxyadenosine (EFdA) or a pharmaceutically acceptable salt thereof.

Abstract: A processing element includes a PIM cluster configured to read data from and write data to an adjacent DRAM subarray, wherein the PIM cluster has a plurality of processing cores, each processing core of the plurality of processing cores containing a look-up table, and a router connected to each processing core, wherein the router is configured to communicate data among each processing core; and a controller unit configured to communicate with the router, wherein the controller unit contains an executable program of operational decomposition algorithms. The look-up tables can be programmable. A DRAM chip including a plurality of DRAM banks, each DRAM bank having a plurality of interleaved DRAM subarrays and a plurality of the PIM clusters configured to read data from and write data to an adjacent DRAM subarray is disclosed.

Abstract: Systems and methods for tracking sympathetic-driven arousal state (SDAS) including nociception under anesthesia is described herein. The method includes obtaining heart rate variability and electrodermal activity of a subject. Point process models are generated for the heart rate variability and the electrodermal activity. A multimodal approach is implemented to determine a state space framework based on these point process models. SDAS can be estimated using the state space framework. In some implementations, an anesthesiologist can modify the dosage of drugs administered to the subject based on this estimation.

Abstract: The Agastache rugosa extract or the isoagastachoside or crude polysaccharide fraction included in the extract according to the present invention can be prepared based on plants being domestically cultivated, and thus is advantageous in terms of time and cost, and can effectively inhibit the differentiation, growth, and bone resorption functions of osteoclast progenitor cells, thus increasing bone density and the like, and accordingly, can be effectively used for the prevention, amelioration, or treatment of diseases related to bone loss caused by differentiation into osteoclasts or excessive activity of osteoclasts. In addition, the active ingredient, which is a plant-derived natural substance, is safe due to fewer side effects on the human body compared to chemical drugs, and inhibits osteoclast progenitor cells independently of estrogen, and thus can be widely used in osteoporosis occurring due to various causes other than menopause.

Abstract: Disclosed are an apparatus and method for providing an offloading service. A method of providing an offloading service according to an example embodiment includes streaming, to a user terminal including a cellular network receiver and a broadcast network receiver, media content data through a cellular network, transmitting, to the user terminal, an offloading service providing signal for activating the broadcast network receiver of the user terminal through the cellular network, transmitting, to the user terminal, a broadcast signal including connection information of a broadcast network to which the user terminal is to be connected so as to receive the media content data, through the cellular network, and broadcasting the media content data through the broadcast network.

Abstract: The present invention relates to a method for scheduling charging of electric vehicles by an electric vehicle charging system, wherein charging objectives to be considered in generating a charging schedule for one or more charging stations of the charging system are obtained, a hierarchy of the charging objectives is determined and the charging schedule is generated by performing a lexicographic optimization based on the hierarchy of the charging objectives.

Abstract: A deep-sea multi-energy integrated platform for complementary power generation, production, living and exploration includes a platform body and a sustainable power supply system, where the platform body includes a column cabin, an upper platform housing, a lower platform housing and a current guide column; the column cabin, the current guide column, the lower platform housing and the upper platform housing are mutually connected to form a triangular platform with a hollow cavity, and a net is disposed in the hollow cavity to form a mariculture zone; the sustainable power supply system includes a wind-driven generator disposed at an end of a top surface of the upper platform housing, a solar panel disposed above a middle portion of the top surface of the upper platform housing, a wave power generation apparatus disposed on the current guide column, and several tidal current power generation apparatuses.

Abstract: Provided are methods and compositions for labeling an allergen-specific pathogenic CD4+ T-cell. The method can comprise contacting a cell population comprising CD4+ T cells with a suspected allergen to provide a challenged cell population, contacting the challenged cell population, or a subpopulation thereof, with a first molecule that specifically binds to a biomarker for an allergen-specific pathogenic T cell, wherein binding of the first molecule to the biomarker on a CD4+ cell indicates the cell is an allergen-specific pathogenic CD4+ T cell, and detecting binding of the first molecule to a CD4+ cell, wherein binding to the cell indicates the cell is an allergen-specific pathogenic CD4+ T cell. The method is applicable to monitoring the presence of allergen-specific pathogenic CD4+ T cells and/or efficacy of immunotherapy for allergies in a subject.

Abstract: A nanocarbon immobilized membrane (NCIM) is disclosed. The nanocarbon immobilized membrane is sized to purify different organic-water mixtures. The nanocarbon immobilized membrane can be used to purify solvents, fuels, and other organic compounds. Data using heptane-water, octane-water, fuel-water, and paint thinner-water show 99.9% separation efficiency. High organic flux is also seen at relatively low pressure. This approach has numerous applications, including fuel purification, oil spills clean-up, separation of commercial emulsions, and solvent purification.

Abstract: This invention provides a method of treating myelodysplastic syndrome in a human subject afflicted therewith comprising administering to the subject an amount from 0.1 mg/m2 to 5 mg/m2 of a compound having the structure or a salt, zwitterion, or ester thereof.

Abstract: Systems and methods for rapid diagnostics related to the use of CRISPR effector systems and optimized guide sequences for detection of coronavirus, including multiplex lateral flow diagnostic devices and methods of use, are provided.

Abstract: An apparatus includes a processor to: receive an indication of ability of a node device to provide a resource for executing application routines, at least one identifier of at least one image including an executable routine stored within a cache of the node device, and an indication of at least one revision level of the at least one image; analyze the ability to provide the resource; in response to being able to support execution of the application routine, identify a first image in a repository; compare identifiers to determine whether there is a second image including a matching executable routine; in response to a match, compare revision levels; and in response to the revision level of the most recent version of the first image being more recent, retrieve the most recent version of the first image from the repository, and store it within the node device.

Abstract: Systems and methods for determining whether a user employs System 1 type thinking or System 2 type thinking when engaged in a task are disclosed. The systems and methods include determining one or more properties of the task based on information regarding the task received from a database storing information regarding the task, determining one or more properties of the user with respect to the task, determining a state of the user based on one or more physiological sensors configured to sense one or more characteristics of the user, and determining that the user employs System 1 type thinking or System 2 type thinking when engaged in the task based on the determined one or more properties of the task, the determined one or more properties of the user, and the determined state of the user.

Abstract: A defoaming composition is composed of a composition E composed of a hydrogen bond donor polyether modified polysiloxane C and a hydrogen bond acceptor X, and a composition F composed of a hydrogen bond donor fatty alcohol polyether D and a hydrogen bond acceptor Y; and the polyether modified polysiloxane C is composed of a polyorganosiloxane A and an allyl polyether B. The general structural formula of the polyorganosiloxane A is R02HSiO (Me2SiO)aSiHR02, where R0 is C1-12 alkyl, cycloalkyl or aryl, and a=10-100. The general structural formula of the allyl polyether B is CH2?CHCH2(OCH2CH2)b(OCH2CHCH3)cOH, where b=1-10, and c=10-100. The general structural formula of the fatty alcohol polyether D is R1(OCH2CH2)m(OCH2CHCH3)nOH, where R1 is C3-20 linear or branched alkyl, cycloalkyl or aralkyl; m=1-50; and n=10-100. The hydrogen bond acceptors X and Y are menthol, menthene, thymol, terpilenol, carveol or perillyl alcohol.

Abstract: An object of the present invention is to develop a novel treatment method for chronic diseases for which conventional treatment methods are either ineffective or for which efficacy is low. The present invention provides a pharmaceutical composition for the treatment and/or prevention of an inflammatory chronic disease that is used in combination with a biological preparation that inhibits leukocyte tissue invasion. The pharmaceutical composition of the present invention contains as an active ingredient thereof siRNA suppressing the expression of CHST15 gene that contains a structure formed by the hybridization of RNA containing the base sequence represented by SEQ ID NO: 1 with RNA complementary thereto.